Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

422 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Induction Chemotherapy and Chemoradiotherapy Combined to ASA vs. Placebo for High-Risk Rectal Cancer: Results of a Randomized Trial.
Ominelli J, Araujo ROC, Valadão M, Padoan MLA, Lopes Dos Santos VM, Dutra JG, Torres CC, Barbosa MA, Guimarães R, Carvalho JCC, Ferreira MA, de Oliveira IM, Small I, de Melo AC, Araujo LH. Ominelli J, et al. Among authors: small i. Clin Colorectal Cancer. 2022 Sep;21(3):e196-e204. doi: 10.1016/j.clcc.2022.05.002. Epub 2022 May 13. Clin Colorectal Cancer. 2022. PMID: 35668002 Clinical Trial.
Adjuvant therapy for non-small cell lung cancer.
França LB, Oliveira MA, Small IÁ, Zukin M, Araújo LH. França LB, et al. J Bras Pneumol. 2011 May-Jun;37(3):354-9. doi: 10.1590/s1806-37132011000300012. J Bras Pneumol. 2011. PMID: 21755191 Free article. English, Portuguese.
OBJECTIVE: Adjuvant chemotherapy is recommended for most patients submitted to resection due to non-small cell lung cancer (NSCLC) staged as II or IIIA. However, although various chemotherapy regimens that include cisplatin have been used in phase III trials, the best choi …
OBJECTIVE: Adjuvant chemotherapy is recommended for most patients submitted to resection due to non-small cell lung cancer (NSCLC) st …
Involvement of signaling molecules in the prediction of response to imatinib treatment in metastatic GIST patients.
Valadão M, Braggio D, Santos AF, Pimenta-Inada HK, Linhares E, Gonçalves R, Romano S, Vilhena B, Small I, Cubero D, Cruz F, Oliveira AT, Martinho O, Reis RM, Guimarães DP, Ferreira CG. Valadão M, et al. Among authors: small i. J Surg Res. 2012 Nov;178(1):288-93. doi: 10.1016/j.jss.2012.03.031. Epub 2012 Apr 5. J Surg Res. 2012. PMID: 22516345
Randomized phase III trial of single-agent pemetrexed versus carboplatin and pemetrexed in patients with advanced non-small-cell lung cancer and Eastern Cooperative Oncology Group performance status of 2.
Zukin M, Barrios CH, Pereira JR, Ribeiro Rde A, Beato CA, do Nascimento YN, Murad A, Franke FA, Precivale M, Araujo LH, Baldotto CS, Vieira FM, Small IA, Ferreira CG, Lilenbaum RC. Zukin M, et al. J Clin Oncol. 2013 Aug 10;31(23):2849-53. doi: 10.1200/JCO.2012.48.1911. Epub 2013 Jun 17. J Clin Oncol. 2013. PMID: 23775961 Clinical Trial.
Does the Sequence of Anthracycline and Taxane Matter? The NeoSAMBA Trial.
Bines J, Small IA, Sarmento R, Kestelman F, Silva S, Rodrigues FR, Faroni L, Gonçalves A, Ebecken E, Maroun P, Millen E, Bonamino M. Bines J, et al. Oncologist. 2020 Sep;25(9):758-764. doi: 10.1634/theoncologist.2019-0805. Epub 2020 Jun 23. Oncologist. 2020. PMID: 32476183 Free PMC article. Clinical Trial.
422 results